Dermatologic Disorders

Resource Center

Resources
Research Summaries FDA Alerts Pearls of Wisdom From the Journal
Insights
Commentary Podcasts Q&As
Interactive
Polls Quizzes
An Atlas of Lumps and Bumps
Photo Essay

FDA Alerts

Skin Cancer
Skin Cancer
FDA Approves First PCSK9 Inhibitor, New Drug for Basal Cell Carcinoma, and More
07/27/2015
The FDA has approved new options for basal cell carcinoma, HIV diagnosis, and high cholesterol that clinicians should be aware of.
07/27/2015
Skin
Skin
FDA: Antipsychotic Drug Could Cause Fatal Skin Reactions
12/12/2014
The FDA has warned of the possibility of serious and sometimes fatal skin reactions associated with an antipsychotic used to treat schizophrenia and bipolar disorder.
12/12/2014